Aaron Grober is a Cardiology physician. OpenAlex indexes 13 publications with 242 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4316 James Casey St Ste C
Austin, TX 787451157
Telephone
512-623-5300Provider last certified this registry record 26 Oct 2023.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year20256 payments
- Inari Medical, Inc.Program year20251 payment
- ABIOMEDProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.6%Beta blocker19.4%Metoprolol Succinate77%Carvedilol23%Part D≥50 patientsStatin14.5%Atorvastatin Calcium62%Rosuvastatin Calcium39%Part D≥29 patients+ 10 more classes in this area
Blood & clotting
11.2%Factor Xa inhibitor7.9%Eliquis100%Part D≥21 patientsP2Y12 inhibitor3.2%Clopidogrel100%Part D≥13 patientsMetabolism & gastrointestinal
6.3%SGLT2 inhibitor4.8%Jardiance100%Part D≥17 patientsProton pump inhibitor1.5%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiopulmonary Bypass is Safe and Effective Support for Concomitant High-Risk Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement
The Journal of invasive cardiology/The journal of invasive cardiology
2026 - Midterm Durability and Structural Valve Degeneration of Transcatheter Aortic Valve Replacement in a Federal Facility
Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery
2022 - Symptom Profiles of a Convenience Sample of Patients with COVID-19 — United States, January–April 2020
MMWR Morbidity and Mortality Weekly Report
2020 - Update on Bicuspid Aortic Valve Syndrome: Patient Selection and Therapies in 2020
Current Treatment Options in Cardiovascular Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”